COVID-19 rapid guideline: delivery of radiotherapy NICE guideline

NICE |  March 2020 | COVID-19 rapid guideline: delivery of radiotherapy [NG162]

The purpose of this guideline is to maximise the safety of patients who need radiotherapy and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for radiotherapy to patient needs if services become limited because of the COVID-19 pandemic.

This guidance was first published on 28 March 2020.

NICE has also produced a COVID-19 rapid guideline on delivery of systemic anticancer treatments.

This guideline is for:

• health and care practitioners
• health and care staff involved in planning and delivering services
• commissioners

The recommendations bring together

• existing national and international guidance and policies
• advice from specialists working in the NHS from across the UK. These include people with expertise and experience of treating patients for the specific health conditions covered by the guidance during the current COVID-19 pandemic.

Full details from NICE

[NICE Consultation] Brain tumours (primary) and brain metastases in adults

NICE |  March 2020 | Brain tumours (primary) and brain metastases in adults | In development [GID-QS10092]

NICE has released a consultation for the 5 key areas for quality improvement which you consider as having the greatest potential to improve the quality of care in this area. 

Closing date for comments: Monday 20 April 2020 at 5pm

Full details from NICE